Literature DB >> 30446753

LAG-3: a very singular immune checkpoint.

Yuan Lui1, Simon J Davis2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30446753      PMCID： PMC7612985          DOI： 10.1038/s41590-018-0257-1

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   31.250


× No keyword cloud information.
  10 in total

1.  Affinity maturation of human CD4 by yeast surface display and crystal structure of a CD4-HLA-DR1 complex.

Authors:  Xin Xiang Wang; Yili Li; Yiyuan Yin; Min Mo; Qian Wang; Wei Gao; Lili Wang; Roy A Mariuzza
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-07       Impact factor: 11.205

2.  MHC class II function preserved by low-affinity peptide interactions preceding stable binding.

Authors:  S Sadegh-Nasseri; L J Stern; D C Wiley; R N Germain
Journal:  Nature       Date:  1994-08-25       Impact factor: 49.962

3.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

4.  Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates.

Authors:  Julie R Brahmer; Charles G Drake; Ira Wollner; John D Powderly; Joel Picus; William H Sharfman; Elizabeth Stankevich; Alice Pons; Theresa M Salay; Tracee L McMiller; Marta M Gilson; Changyu Wang; Mark Selby; Janis M Taube; Robert Anders; Lieping Chen; Alan J Korman; Drew M Pardoll; Israel Lowy; Suzanne L Topalian
Journal:  J Clin Oncol       Date:  2010-06-01       Impact factor: 44.544

5.  Crystal structure of the HLA-DM-HLA-DR1 complex defines mechanisms for rapid peptide selection.

Authors:  Wouter Pos; Dhruv K Sethi; Melissa J Call; Monika-Sarah E D Schulze; Anne-Kathrin Anders; Jason Pyrdol; Kai W Wucherpfennig
Journal:  Cell       Date:  2012-12-21       Impact factor: 41.582

6.  Register shifting of an insulin peptide-MHC complex allows diabetogenic T cells to escape thymic deletion.

Authors:  James F Mohan; Shirley J Petzold; Emil R Unanue
Journal:  J Exp Med       Date:  2011-11-07       Impact factor: 14.307

7.  LAG-3, a novel lymphocyte activation gene closely related to CD4.

Authors:  F Triebel; S Jitsukawa; E Baixeras; S Roman-Roman; C Genevee; E Viegas-Pequignot; T Hercend
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

8.  Genome-scale identification of cellular pathways required for cell surface recognition.

Authors:  Sumana Sharma; S Josefin Bartholdson; Amalie C M Couch; Kosuke Yusa; Gavin J Wright
Journal:  Genome Res       Date:  2018-06-18       Impact factor: 9.043

9.  Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens.

Authors:  E Baixeras; B Huard; C Miossec; S Jitsukawa; M Martin; T Hercend; C Auffray; F Triebel; D Piatier-Tonneau
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

Review 10.  Beyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint Regulators.

Authors:  Isabelle Le Mercier; J Louise Lines; Randolph J Noelle
Journal:  Front Immunol       Date:  2015-08-21       Impact factor: 7.561
  10 in total
  10 in total

Review 1.  Checkpoint Molecules in Rheumatology-or the Benefits of Being Exhausted.

Authors:  Stinne Ravn Greisen; Bent Deleuran
Journal:  Curr Rheumatol Rep       Date:  2021-03-02       Impact factor: 4.592

2.  LAG3 ectodomain structure reveals functional interfaces for ligand and antibody recognition.

Authors:  Qianqian Ming; Daiana P Celias; Chao Wu; Aidan R Cole; Srishti Singh; Charlotte Mason; Shen Dong; Timothy H Tran; Gaya K Amarasinghe; Brian Ruffell; Vincent C Luca
Journal:  Nat Immunol       Date:  2022-06-27       Impact factor: 31.250

3.  Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression.

Authors:  Yu Mei; Wenya Linda Bi; James Agolia; Changchen Hu; Alexandra M Giantini Larsen; David M Meredith; Sally Al Abdulmohsen; Tejus Bale; Gavin P Dunn; Malak Abedalthagafi; Ian F Dunn
Journal:  Pituitary       Date:  2021-01-25       Impact factor: 4.107

4.  Microglia promote glioblastoma via mTOR-mediated immunosuppression of the tumour microenvironment.

Authors:  Anaelle A Dumas; Nicola Pomella; Gabriel Rosser; Loredana Guglielmi; Claire Vinel; Thomas O Millner; Jeremy Rees; Natasha Aley; Denise Sheer; Jun Wei; Anantha Marisetty; Amy B Heimberger; Robert L Bowman; Sebastian Brandner; Johanna A Joyce; Silvia Marino
Journal:  EMBO J       Date:  2020-06-22       Impact factor: 11.598

Review 5.  LAG3: The Biological Processes That Motivate Targeting This Immune Checkpoint Molecule in Human Cancer.

Authors:  Cinzia Solinas; Edoardo Migliori; Pushpamali De Silva; Karen Willard-Gallo
Journal:  Cancers (Basel)       Date:  2019-08-20       Impact factor: 6.639

Review 6.  A Highlight of the Mechanisms of Immune Checkpoint Blocker Resistance.

Authors:  Qian Huang; Yanna Lei; Xiaoying Li; Fukun Guo; Ming Liu
Journal:  Front Cell Dev Biol       Date:  2020-12-04

7.  Retrospective analysis of the preparation and application of immunotherapy in cancer treatment (Review).

Authors:  Jiachen Lu; Jianing Ding; Zhaoxia Liu; Tingtao Chen
Journal:  Int J Oncol       Date:  2022-01-04       Impact factor: 5.650

Review 8.  What Happens to the Immune Microenvironment After PD-1 Inhibitor Therapy?

Authors:  Qingyi Wang; Bin Xie; Shuang Liu; Ying Shi; Yongguang Tao; Desheng Xiao; Wenxiang Wang
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

Review 9.  Prognostic significance and therapeutic potentials of immune checkpoints in osteosarcoma.

Authors:  Vafa Meftahpour; Ali Aghebati-Maleki; Ali Fotouhi; Elham Safarzadeh; Leili Aghebati-Maleki
Journal:  EXCLI J       Date:  2022-01-12       Impact factor: 4.068

10.  Serafino Zappacosta: An Enlightened Mentor and Educator.

Authors:  Ennio Carbone; Mario De Felice; Francesca Di Rosa; Ugo D'Oro; Silvia Fontana; Antonio La Cava; Michele Maio; Giuseppe Matarese; Luigi Racioppi; Giuseppina Ruggiero; Giuseppe Terrazzano
Journal:  Front Immunol       Date:  2020-02-13       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.